Approval · Notice of Compliance 31880 · 2023
AMVUTTRA: Notice of Compliance 31880
Issued October 18, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31880
- Date
- October 18, 2023
- Company
- Alnylam Netherlands B.V.Amsterdam, Netherlands
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AMVUTTRA | 02542420 | Marketed |
Medicinal ingredients
- VUTRISIRAN 25 MG per 0.5ML